Headache mechanisms: what we still do not know
Brain Conflux · 2025
DOI: 10.71321/h9jhnr48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Conflux, 2025. Verfasst von Yiqin Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary headaches such as migraine, cluster headache (CH), and tension-type headache (TTH) are highly prevalent neurological disorders with complex and heterogeneous pathophysiology. Traditionally attributed to either vascular or neuronal origins, current evidence supports a neurovascular model involving dynamic interactions between the nervous system and cranial. This Perspective examines the role of two key neuropeptides – calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) – in the generation of primary headaches. CGRP is a validated target in migraine, but its clinical utility is limited by biomarker instability and a significant proportion of non-responders. PACAP is emerging as a complementary target, though its receptor mechanisms remain incompletely understood. While neither CGRP nor PACAP appear to play a major role in TTH, their contribution to migraine and CH highlights the need for precision approaches based on molecular endophenotypes. Understanding these mechanisms may inform the development of more effective, personalized headache treatments.
Zitieren
APA
Liu, Y., Wang, W., & Pellesi, L. (2025). Headache mechanisms: what we still do not know. Brain Conflux. https://doi.org/10.71321/h9jhnr48
Vancouver
Liu Y, Wang W, Pellesi L. Headache mechanisms: what we still do not know. Brain Conflux. 2025. doi:10.71321/h9jhnr48
BibTeX
@article{Liu2025,
author = {Liu, Yiqin and Wang, Wei and Pellesi, Lanfranco},
title = {Headache mechanisms: what we still do not know},
journal = {Brain Conflux},
year = {2025},
doi = {10.71321/h9jhnr48}
}
EUVIMED